A.I. Virtanen Institute for Molecular Sciences - News

Researchers identified key developmental and molecular differences between the two main subtypes of chronic lymphocytic leukemia.

The Research Council of Finland has granted continued funding for the GeneCellNano, UNITE and ACCC Flagships for the period 2026–2028.

The Research Council of Finland granted funding to promote research utilisation.

When biomedicine students Yasin Arafat and Nafee Alam began their studies, they were keen to expand their scientific interests into new areas.

The community's symposium presentations highlighted how interdisciplinary approaches are essential for understanding the complexity of cardiovascular diseases and advancing their prevention, diagnostics and therapeutics.

Neurons produced from frontotemporal dementia patients’ skin biopsies using modern stem cell technology recapitulate the synaptic loss and dysfunction detected in the patients’ brains.

After TBI, some people develop epilepsy months or even years later. The doctoral research of Pedro Andrade, MSc, explores how and why this happens, using advanced brain monitoring techniques in animal models.

The widely used antidepressant fluoxetine does more than boost serotonin levels: it changes how brain cells manage their energy and rebuild their connections.

Polina Abushik, Anni Hartikainen, Soila Lemmetty, Iuliia Pilipenko, Isabell Rumrich, Atte Eskelinen and Henri Hyvönen were appointed to three-year UEF Research Fellow positions.

The University of Aveiro has joined the MIRACLE research project to develop more accurate and personalised methods for cardiovascular disease risk assessment, prevention, and treatment.